rs104894128
Variant summary
Our verdict is Likely pathogenic. The variant received 7 ACMG points: 7P and 0B. PM1PM2PP2PP3_Moderate
The NM_003289.4(TPM2):c.440A>C(p.Gln147Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003289.4 missense
Scores
Clinical Significance
Conservation
Publications
- TPM2-related myopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- arthrogryposis, distal, type 1AInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- congenital myopathy 23Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- congenital myopathyInheritance: AR Classification: MODERATE Submitted by: Ambry Genetics
- cap myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- childhood-onset nemaline myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- congenital fiber-type disproportion myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- digitotalar dysmorphismInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Sheldon-hall syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- typical nemaline myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 7 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TPM2 | NM_003289.4 | c.440A>C | p.Gln147Pro | missense_variant | Exon 4 of 9 | ENST00000645482.3 | NP_003280.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TPM2 | ENST00000645482.3 | c.440A>C | p.Gln147Pro | missense_variant | Exon 4 of 9 | NM_003289.4 | ENSP00000496494.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 35
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Congenital myopathy 23 Pathogenic:1
- -
Arthrogryposis, distal, type 1A Uncertain:1
This sequence change replaces glutamine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 147 of the TPM2 protein (p.Gln147Pro). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with nemaline myopathy (PMID: 11738357). ClinVar contains an entry for this variant (Variation ID: 12461). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TPM2 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects TPM2 function (PMID: 22084935, 26708479, 30545627). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at